Why is Access to Asthma Care Not Equal?

	Respiratory Diseases
	The latest respiratory diseases news from News Medical

Asthma is a common long-term health condition, so why does access to diagnosis and treatment still depend on where you live, who you see, or even your ethnicity?
To mark World Asthma Day, we spoke with Carol Stonham MBE about accessibility in asthma care and why we are not there yet.

			One RSV shot cuts severe lung infections in older adults for three seasons, trial shows A phase 3 trial involving nearly 25,000 older adults across 17 countries found that a single dose of the RSVPreF3 OA vaccine reduced RSV-related lower respiratory tract disease by 63% over three seasons. Protection remained substantial despite waning, with similar efficacy to a two-dose regimen and a favorable safety profile.

			Some lung cancer patients maintain long-term control after stopping immunotherapy A subset of patients with non-small cell lung cancer (NSCLC) who discontinued immune checkpoint inhibitor (ICI) therapy due to immune-related adverse events (irAEs) continued to experience long-term disease control.

	Historic decline in smoking across the United States largely driven by young adults Researchers at University of California San Diego found that cigarette smoking continues to decline across the United States, largely driven by young adults.

	New analysis clarified the link between "exclusive" use of e-cigarettes and COPD A Johns Hopkins Medicine-led analysis of medical information gathered on a diverse group of almost 250,000 people over four years has significantly clarified the link between the "exclusive" use of e-cigarettes and chronic obstructive pulmonary disease (COPD), as well as high blood pressure in a sub-group of adults 30 to 70 years of age.

	What the Newest mRNA Vaccines Could Do Beyond COVID Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from COVID-19 to personalized cancer therapies.

	AI tool helps GPs spot lung cancer risk months earlier GPs may soon be able to identify patients with an increased risk of lung cancer up to 4 months earlier than is currently the case.

	The dual role of microRNAs in lung cancer progression and suppression Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).

How would you rate today's newsletter?

Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2025